During the past decade, Providence Medical Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 22 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Medical Group" #1 sponsor was "SCRI Development Innovations, LLC" with 20 trials, followed by "Hoosier Cancer Research Network" with 6 trials sponsored, "CTI BioPharma" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "HiberCell, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Medical Group" #1 collaborator was "Genentech, Inc." with 7 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Bayer" with 3 trials as a collaborator and "Walther Cancer Institute" with 3 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Providence Medical Group" are "Non-Small Cell Lung Cancer" (7 trials), "Breast Cancer" (5 trials), "Metastatic Breast Cancer" (3 trials), "Lung Cancer" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Providence Medical Group" in a lesser frequency.

Most popular intervention types in "Providence Medical Group" are "Drug" (32 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (9 trials), "Bevacizumab" (5 trials), "Paclitaxel" (5 trials), "Ixabepilone" (4 trials) and "Rituximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Providence Medical Group" are 23 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Providence Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Providence Medical Group, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Medical Group, 4 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".